Douglas M. Bibus

Total Fat Intake Modifies Plasma Fatty Acid Composition in Humans

Susan K. Raatz, Douglas M. Bibus, William Thomas et al. · Journal of Nutrition · 2001 · 166 citations

Obesity, Metabolic Syndrome, Nutrition +8

Comparison of Low-Fat Versus Mediterranean-Style Dietary Intervention After First Myocardial Infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial)††Conflicts of interest: Dr. Bibus has received consulting fees from companies that make fish oil, Coromega Co., Vista, CA, and Enreco, Inc., Newton, WI. He also has equity ownership in Lipid Technologies, LLC, Austin, MN, the company that performed the plasma fatty acid analysis. Dr. Bibus owns patents related to lipid therapy. He has served as an expert witness regarding lipids and fatty acids.

Katherine R. Tuttle, Lynn A. Shuler, Diane P. Packard et al. · The American Journal of Cardiology · 2008 · 125 citations

Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells

Guang‐Ming Liu, Douglas M. Bibus, Ann M. Bode et al. · Proceedings of the National Academy of Sciences · 2001 · 110 citations · Full text

Nanomolar vitamin E α‐tocotrienol inhibits glutamate‐induced activation of phospholipase A₂ and causes neuroprotection

Savita Khanna, Narasimham L. Parinandi, Sainath R. Kotha et al. · Journal of Neurochemistry · 2009 · 100 citations

Lipid Peroxidation, Cell Death, Nm Tct +17

Enhanced Absorption of n-3 Fatty Acids from Emulsified Compared with Encapsulated Fish Oil

Susan K. Raatz, J. Bruce Redmon, N. Wimmergren et al. · Journal of the American Dietetic Association · 2009 · 97 citations · Full text

Food Chemistry, Emulsified Compared, Omega-3 Fatty Acid +5